VIVIMUSTA

BENDAMUSTINE HYDROCHLORIDE · Azurity Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VIVIMUSTA, covering 2022-12-07 to 2024-02-27. Get the full timeline:

Most recent: FDA Approved: VIVIMUSTA — Supplemental Application (Azurity Pharmaceuticals, Inc.)